Related Experiment Video
Updated: Jun 30, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Persistent Dominance of Serotype 3 in Noninvasive Pneumococcal Disease in Belgium (2022-2025)
I Passaris1, S Depickère2, M Maex1
1Bacterial Diseases Unit, Sciensano, Brussels, Belgium.
Abstract:
Noninvasive pneumococcal disease (NIPD) represents a substantial portion of the total pneumococcal disease burden worldwide. In this cross-sectional study, the serotype distribution for isolates originating from NIPD patients in Belgium (2022-2025) is described. Serotype 3 was the serotype with the largest NIPD burden in Belgium (n = 178, 12.7%), and detailed analyses revealed that its burden was lower in infants <2 years when compared to older age groups. Pneumococcal conjugate vaccines PCV20 and PCV21 cover approximately 50% to 80%, respectively, of circulating serotypes responsible for NIPD in Belgium, which underlines the importance of improving vaccine uptake in the adult population.
Related Concept Videos
Streptococcal Pharyngitis
Infectious Diseases and Their Occurrence
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Atypical Pneumonia
Bacterial Meningitis

